Evidence map›Paper›PMID 7896567›Full record

ArticleThe Histochemical journal1994

The expression of vimentin in satellite cells of regenerating skeletal muscle in vivo.

R Vater, M J Cullen, J B Harris

Abstract read
PubMed
In one paragraph

Article in The Histochemical journal, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. The evolution of vimentin and desmin inFrontiers in physiology · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Retention of Pax3 expression in satellite cells of muscle spindles.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2010
    Article
  9. Article
  10. Diagnostic protein expression in human muscle biopsies.Brain pathology (Zurich, Switzerland) · 2000
    Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

R VaterRegional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK.
M J Cullen
J B Harris
North Tyneside General Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of the intermediate filament protein, vimentin, was studied in skeletal muscle during a cycle of degeneration and regeneration. Venom from the Australian tiger snake, Notechis scutatus scutatus, was used to initiate the breakdown of the soleus muscle of young, mature rats in vivo. Cryosections and Western blots of muscle samples were labelled using antibodies to vimentin, and examined at fixed time points after venom injection. Vimentin was absent in control adult muscle fibres, but was identified in activated satellite cells 12 h after venom assault. The amount of this protein rose during the early stages of regeneration, reaching its peak at 2-3 days. At this time, the expression of muscle-specific intermediate filament protein, desmin, began. As the abundance of desmin increased with the maturation of the regenerating myofibres, the abundance of vimentin declined until it was no longer detectable in mature regenerated fibres. It is suggested that vimentin plays an important role during satellite cell activation in the early stages of regeneration, and that the expression of vimentin may act as a stimulus for the expression of desmin at later stages of regeneration.

Indexed as

AnimalsBlotting, WesternCell DivisionDesminFemaleFluorescent Antibody TechniqueImmunohistochemistryMicroscopy, ImmunoelectronMuscle, SkeletalRatsRats, WistarRegenerationSnake VenomsVimentinDesminSnake VenomsVimentin

Identifiers

PMID7896567
OpenAlexW2059456240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.